PharVision Advisers
RIG icon

PharVision Advisers’s Transocean RIG Stock Holding History

PharVision Advisers’s Portfolio RIG Stock Details RIG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.8K Sell
12,754
-2,211
-15% -$12.1K 2.71% 15
2026
Q2 		$73.2K Sell
14,965
-5,374
-26% -$33.6K 1.38% 40
2026
Q1 		$135K Buy
+20,339
New +$115K 1.37% 19

Other funds holding RIG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $9.18B AUM 10.37% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.6B AUM 20.91% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

PharVision Advisers's RIG Position: Q3 2026 in Review

PharVision Advisers reduced its Transocean (RIG) stake by 15% in Q3 2026, selling an estimated $12.1K and leaving 12,754 shares worth $66.8K. The position accounts for 2.71% of the portfolio, ranked #15.

PharVision Advisers first reported a position in RIG in Q1 2026 and has held it in 3 quarters since. The position peaked at $135K in Q1 2026. 356 funds tracked by Wall St. Rank hold RIG as of Q3 2026.

  • PharVision Advisers held 12,754 shares of Transocean worth $66.8K as of Q3 2026.
  • PharVision Advisers sold 2,211 Transocean shares in Q3 2026, an estimated $12.1K.
  • Transocean made up 2.71% of PharVision Advisers's portfolio in Q3 2026, its #15 holding.
  • PharVision Advisers first reported a position in Transocean in Q1 2026 and has held it in 3 quarters since.
  • PharVision Advisers's Transocean position peaked at $135K in Q1 2026.
  • 356 funds tracked by Wall St. Rank held Transocean as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.